Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752842 · ClinicalTrials.gov registry record · NA
Lipid Biomarkers for Diabetic Heart Disease
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT01752842 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 70 participants.
The verdict
NCT01752842, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
Interventions
- DRUG Fenofibrate
- DRUG Placebo for fenofibrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2013-03 |
| Est. Completion | 2018-02-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01752842
The ClinicalTrials.gov registry entry for NCT01752842 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fenofibrate is the first listed.
NCT01752842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01752842 about?
NCT01752842 is a clinical study titled "Lipid Biomarkers for Diabetic Heart Disease". This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
What is the current status of trial NCT01752842?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2013-03. Estimated completion is 2018-02-23.
What interventions are being tested in trial NCT01752842?
The interventions under investigation include: Fenofibrate (DRUG), Placebo for fenofibrate (DRUG).
Who is sponsoring clinical trial NCT01752842?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.